Jennifer C. Munoz Pareja, M.D.
Professor Pediatric Critical Care, University of Miami
Dr. Munoz Pareja is an Associate Professor in the Division of Pediatric Critical Care and The Miami Project to Cure Paralysis. She obtained her medical degree from Universidad del Norte in Colombia and completed her pediatric residency at Nicklaus Children’s Hospital in Miami, FL. Following that, she pursued a pediatric critical care fellowship at Massachusetts General Hospital, Harvard Medical School.
Dr. Munoz’s research primarily centers around the utilization of brain biomarkers to aid in the diagnosis and prognosis of brain injury response and recovery following trauma and various neurological conditions in the intensive care unit. Additionally, she serves as the Emergency Neurological Life Support (ENLS) chair for the Neurocritical Care Society (NCS) and the President Elect for the Pediatric Neurocritical Care Research Group (PNCRG).
Moreover, Dr. Munoz demonstrates a strong commitment to delivering high-quality healthcare to underserved populations. She actively participates in multiple international organizations dedicated to providing optimal neurocritical care to children worldwide.
I am also actively leading these two international programs:
P-ICONIC
Dr. Muñoz Pareja leads P-ICONIC (Pediatric Non-Invasive ICP Consensus), an international collaborative initiative dedicated to advancing non-invasive neuromonitoring in children with acute brain injury through evidence synthesis, expert consensus, and global scientific partnership.
PNC3
Dr. Muñoz Pareja is a leader in PNC3 (Pediatric Neurocritical Care Course), an international educational initiative focused on improving the recognition and management of pediatric neurologic emergencies through high-yield, evidence-based training for clinicians worldwide.
Biomarkers in Acute Brain Injury
The overarching goal of my laboratory is to gain a comprehensive understanding of the diverse pathomechanisms contributing to adverse outcomes in pediatric acute brain injury. We strive to identify specific biomarkers that can be employed as objective measures for assessing the severity of pediatric acute brain injury, as well as predicting patient outcomes. Moreover, recognizing neuroinflammation as a central pathophysiological aspect of acute brain injury and acknowledging that a limited understanding of the intricate cellular and molecular sequelae has hindered previous translational efforts, my current focus centers around studying the role of the inflammasome in the innate immune response following injury. By accomplishing this, we aim to enhance our ability to evaluate injury severity and provide valuable prognostic and therapeutic information to this vulnerable population.
Visit Dr. Munoz Pareja’s Publication Listing
Inflammasome Proteins Improve Pediatric Traumatic Brain Injury Assessment
Professional Affiliations / Memberships
| 2008 – Present | American Academy of Pediatrics (AAP) |
| 2011 – Present | Society of Critical Care Medicine (SCCM) |
| 2015 – Present | Neurocritical Care Society (NCS) |
| 2019 – Present- | Pediatric Neurocritical Care Research Group (PNCRG) |